Xarelto Lawsuit Cases Continue To Draw Support And Attention

September 14, 2016 – – TheProductLawyers.com reports on the recent developments in regards to the multitude of cases brought against the manufacturers of the anticoagulant drug, Xarelto. Lawsuits seeking damages from the manufacturers Bayer AG and Janssen Pharmaceuticals (a division of Johnson & Johnson) have surpassed 3,000 in number, and many allege similar harm as a result of taking the drug.

To the ends of expediting the process, the U.S. Judicial Panel on Multidistrict Litigation elected to merge 2,800 individual cases into the multidistrict litigation (MDL) case No. 2592. The combination lawsuit will be tried in the Eastern District of Louisiana. A similar agglomeration occurred in Pennsylvania, where 550 cases merged to form a mass tort program, completed by the Philadelphia Court of Common Pleas.

The rationale motivating these combinations lies in the similarity of stated grievances and the allegations brought against the drug manufacturers. Individuals claim that, because neither they nor their physicians were appropriately apprised of the possible elevated risk for the occurrence of sudden dangerous bleeding episodes associated with taking the drug, they were placed in danger of harm without due knowledge.

The FDA granted approval to the new-generation anticoagulant in 2011. It was originally intended for use by those suffering from pulmonary embolism or deep vein thrombosis and as a preventative measure for those recovering from hip or knee replacement surgery. Its approved uses were expanded shortly thereafter to treat individuals with atrial fibrillation, a heart condition that increases the risk for stroke.

While the cases have not yet gone to trial, plaintiffs are offered a measure of comfort. In the recent past, a similar case was made against the drug Pradaxa, which resulted in a multitude of lawsuits, which were settled out of court.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60012178